1
Reactions 467 - 4 Sep 1993 The US FDA is to investigate the toxicity of chloral hydrate, in conjunction with the National Institute of Environmental Health Sciences. The FDA decision follows identification of tumour-forming properties of the drug in mice. Although other animal studies have suggested that the drug may be mutagenic and genotoxic, the FDA says that at present there is no epidemiological evidence of the drug being a risk to humans. Chloral hydrate under suspicion. Reactions 467: 4, 4 Sep 1993 800216819 1 Reactions 4 Sep 1993 No. 467 0114-9954/10/0467-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

The US FDA is to investigate the toxicity of chloral hydrate

Embed Size (px)

Citation preview

Page 1: The US FDA is to investigate the toxicity of chloral hydrate

Reactions 467 - 4 Sep 1993

■ The US FDA is to investigate the toxicity of chloralhydrate, in conjunction with the National Institute ofEnvironmental Health Sciences. The FDA decisionfollows identification of tumour-forming properties ofthe drug in mice. Although other animal studies havesuggested that the drug may be mutagenic andgenotoxic, the FDA says that at present there is noepidemiological evidence of the drug being a risk tohumans.Chloral hydrate under suspicion. Reactions 467: 4, 4 Sep 1993 800216819

1

Reactions 4 Sep 1993 No. 4670114-9954/10/0467-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved